Integrated Biopharma, Inc.
INBP
$0.30
$0.00-0.27%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -206.00K | 672.00K | 808.00K | 1.25M | 928.00K |
| Total Depreciation and Amortization | 1.29M | 1.28M | 1.27M | 1.26M | 1.26M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.16M | 1.36M | 1.49M | 775.00K | 659.00K |
| Change in Net Operating Assets | 883.00K | -596.00K | -1.50M | -2.00M | -531.00K |
| Cash from Operations | 3.13M | 2.71M | 2.07M | 1.29M | 2.32M |
| Capital Expenditure | -303.00K | -308.00K | -191.00K | -347.00K | -576.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.00K | -14.00K | -14.00K | -- | -- |
| Cash from Investing | -317.00K | -322.00K | -205.00K | -347.00K | -576.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -23.00K | -12.00K | -8.00K | -18.00K | -28.00K |
| Issuance of Common Stock | 68.00K | 86.00K | 86.00K | 18.00K | 18.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 45.00K | 74.00K | 78.00K | 0.00 | -10.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.85M | 2.46M | 1.94M | 941.00K | 1.73M |